Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
20 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Vericel Corporation’s names, not what it holds today.
Patents granted
20
20 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 2 in 2024 and none in 2023
Applications published
21
2 of them in 2025
Names they are printed under
4
a former name, its own name
By yearGrantedApplications published
'04'06'07'10'11'12'13'14'15'16'18'21'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Aastrom Biosciences, Inc. a former name
US, as the owner printed on each patent
13 publishedVericel Corporation its own name
named as the applicant on its applications, in US
7 publishedVericel Corporation its own name
US, as the owner printed on each patent
0 publishedAastrom Biosciences, Inc. a former name
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 16, 2025 | 12,496,317 | Compositions and methods for repairing cartilage defects | Medical technology | Vericel Corporation |
| Jan 2, 2024 | 11,857,576 | Compositions and methods for repairing cartilage defects | Medical technology | Vericel Corporation |
| Jan 2, 2024 | 11,857,170 | Methods and devices for repairing cartilage defects | Medical technology | Vericel Corporation |
| Jul 3, 2018 | 10,011,811 | Cell seeding device and method | Biotechnology | Vericel Corporation |
| Aug 16, 2016 | 9,415,071 | Mixed cell populations for tissue repair and separation technique for cell processing | Pharmaceuticals | Vericel Corporation |
| Jul 15, 2014 | 8,778,330 | En vivo generated tissue system | Biotechnology | Aastrom Biosciences, Inc. |
| Mar 12, 2013 | 8,394,632 | Ex vivo generated tissue system | Biotechnology | Aastrom Biosciences, Inc. |
| Mar 12, 2013 | 8,394,631 | Mixed cell populations for tissue repair and separation technique for cell processing | Pharmaceuticals | Aastrom Biosciences, Inc. |
| Apr 17, 2012 | 8,158,122 | Mixed cell populations for tissue repair and separation technique for cell processing | Pharmaceuticals | Aastrom Biosciences, Inc. |
| Jan 18, 2011 | 7,871,605 | Mixed cell populations for tissue repair and separation technique for cell processing | Pharmaceuticals | Aastrom Biosciences, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| May 22, 2025 | 2025/0161073 | METHODS AND DEVICES FOR REPAIRING CARTILAGE DEFECTS | Medical technology | Vericel Corporation |
| Jan 2, 2025 | 2025/0000672 | METHODS FOR REPAIRING CARTILAGE DEFECTS | Medical technology | Vericel Corporation |
| Apr 4, 2024 | 2024/0108660 | COMPOSITIONS AND METHODS FOR REPAIRING CARTILAGE DEFECTS | Medical technology | Vericel Corporation · patent 12,496,317 granted from it |
| Sep 7, 2023 | 2023/0277163 | METHODS AND DEVICES FOR REPAIRING CARTILAGE DEFECTS | Medical technology | Vericel Corporation · patent 11,857,170 granted from it |
| Feb 25, 2021 | 2021/0052661 | COMPOSITIONS AND METHODS FOR REPAIRING CARTILAGE DEFECTS | Medical technology | Vericel Corporation · patent 11,857,576 granted from it |
| Sep 27, 2018 | 2018/0273889 | CELL SEEDING DEVICE AND METHOD | Biotechnology | Vericel Corporation |
| Nov 3, 2016 | 2016/0317584 | Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing | Pharmaceuticals | Vericel Corporation |
| Mar 26, 2015 | 2015/0086520 | Cell Compositions and Methods of Using Same | Pharmaceuticals | Aastrom Biosciences, Inc. |
| Jul 10, 2014 | 2014/0193375 | Mesenchymal Stromal Cell Populations and Methods of Making Same | Pharmaceuticals | Aastrom Biosciences, Inc. |
| Apr 10, 2014 | 2014/0099292 | CD14+ Cell Compositions and Methods of Using Same | Pharmaceuticals | Aastrom Biosciences, Inc. |
What it applied for, 2024 to 2025: Medical technology 3.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.